Literature DB >> 3335503

Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells.

J L Sherley1, T J Kelly.   

Abstract

The mammalian cytosolic thymidine kinase is one of a number of enzymes involved in DNA replication whose activities increase dramatically during S phase of the cell cycle. As a first step in defining the mechanisms that control the S phase induction of thymidine kinase activity, we have purified the human enzyme from HeLa cells and raised a specific immune serum against the purified protein. The enzyme was isolated from cells arrested in S phase by treatment with methotrexate and purified to near homogeneity by ion-exchange and affinity chromatography. Stabilization of the purified enzyme was achieved by the addition of digitonin. An electrophoretic Rm of 0.2 in nondenaturing gels characterizes the purified enzyme activity as cytosolic thymidine kinase. The enzyme has a Stoke's radius of 40 A determined by gel filtration and a sedimentation coefficient of 5.5 S determined by glycerol gradient sedimentation. Based on these hydrodynamic values, a native molecular weight of 96,000 was calculated for the purified enzyme. When electrophoresed in denaturing sodium dodecyl sulfate-polyacrylamide gels under reducing conditions, the most purified enzyme fraction was found to contain one predominant polypeptide of Mr = 24,000. Several lines of evidence indicate that this polypeptide is responsible for thymidine kinase enzymatic activity. 1) The Mr = 24,000 polypeptide co-migrates with thymidine kinase activity in electrophoretic and sedimentation analyses. 2) A subunit Mr = 25,504 is predicted by the nucleotide sequence of a recently isolated cDNA clone that encodes HeLa thymidine kinase. 3) Mouse LTK- cells transformed with this clone express a cytosolic thymidine kinase activity, as well as a novel Mr = 24,000 polypeptide detectable with immune serum raised against the purified human enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335503

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Human deoxycytidine kinase is located in the cell nucleus.

Authors:  M Johansson; S Brismar; A Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis.

Authors:  M G Kauffman; T J Kelly
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

3.  Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.

Authors:  Seung Jin Lee; Hye Young Kang; Seog Young Kim; Jin Hwa Chung; Seung Jun Oh; Jin-Sook Ryu; Sung-Bae Kim; Jong Soon Kang; Song-Kyu Park; Hwan Mook Kim; Myung-Hwa Kim; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

Review 4.  Cooperativity in monomeric enzymes with single ligand-binding sites.

Authors:  Carol M Porter; Brian G Miller
Journal:  Bioorg Chem       Date:  2011-11-17       Impact factor: 5.275

5.  G1 cyclin degradation: the PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover.

Authors:  S R Salama; K B Hendricks; J Thorner
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.

Authors:  Hitesh K Agarwal; Craig A McElroy; Elena Sjuvarsson; Staffan Eriksson; Michael V Darby; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-12-05       Impact factor: 6.514

7.  Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine.

Authors:  D J Medina; P P Tung; M B Lerner-Tung; C J Nelson; J W Mellors; R K Strair
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 8.  The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.

Authors:  Sridhar Nimmagadda; Anthony F Shields
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

9.  Mass action models versus the Hill model: an analysis of tetrameric human thymidine kinase 1 positive cooperativity.

Authors:  Tomas Radivoyevitch
Journal:  Biol Direct       Date:  2009-12-09       Impact factor: 4.540

10.  Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.

Authors:  Ofelia A Olivero; Irma L Vazquez; Catherine C Cooch; Jessica Ming; Emily Keller; Mia Yu; Jennifer P Borojerdi; Hannan M Braun; Edward McKee; Miriam C Poirier
Journal:  Toxicol Sci       Date:  2010-01-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.